Shaping the Breast Biopsy Market in 2025: nnovative Dual Vacuum-Assisted Breast Biopsy System Enhances Precision And Patient Comfort

How Big Is the Breast Biopsy Market Expected to Be, and What Will Its Growth Rate Be?
Over the past few years, there has been significant growth in the size of the breast biopsy market. The market, which is projected to rise from $1.42 billion in 2024 to $1.53 billion in 2025, is on track for a compound annual growth rate (CAGR) of 7.6%. Factors such as the increasing prevalence of breast cancer, an aging population, expanded awareness initiatives, higher healthcare spending, and a move towards outpatient and ambulatory environments have been instrumental in the historical growth period.

Anticipated to experience substantial expansion in the coming years, the breast biopsy market is predicted to achieve a value of $2.03 billion by 2029, with a compound annual growth rate (CAGR) of 7.3%. Factors contributing to this prospective growth primarily include the evolution of infrastructure within the healthcare industry, the rise in personalized medicine, an increase in healthcare accessibility within developing regions, supportive regulations and reimbursement policies, and the emergence of telemedicine and remote diagnostics. Significant trends slated to mark the forecast period include the implementation of robotics in biopsy procedures, the proliferation of home-based biopsy kits, the increasing relevance of genomic biopsies, a shift towards patient-centered care models, the application of blockchain for data protection, and an emphasis on post-biopsy monitoring tools.

What Are the Primary Growth Drivers for the Breast Biopsy Market?
The escalating incidence of breast cancer is anticipated to fuel the expansion of the breast biopsy market in the future. Breast cancer is a harmful tumor that originates in the cells of breast tissue and can metastasize to other body parts if not immediately treated. The incidence of breast cancer is linked to aspects like longer lifespan, enhanced detection techniques, and increased disease awareness. A breast biopsy, which extracts tissue samples from suspected areas in the breast to diagnose and determine the features of breast cancer, is used for cancer detection. For example, as stated by the American Cancer Society, a non-profit organization based in the US, the count of new invasive breast cancer instances in American females escalated from about 281,550 in 2021 to 297,790 in January 2023. Consequently, the rising incidence of breast cancer is pushing the growth of the breast biopsy market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19348&type=smp

Who Are the Dominant Companies Influencing Breast Biopsy Market Trends?
Major companies operating in the breast biopsy market are Medtronic PLC, Siemens Healthineers AG, Fujifilm Holdings Corporation, Becton Dickinson and Company (BD), Koninklijke Philips, GE HealthCare Technologies Inc., Hologic Inc., The Cooper Companies Inc., Merit Medical Systems, Argon Medical Devices, Canon Medical Systems Corporation, Devicor Medical Products Inc., Mermaid Medical Group, Planmed Oy, Menarini-Silicon Biosystems, Seno Medical Instruments Inc., Surgical Innovations Group, Sterylab Srl, Dilon Technologies Inc., INRAD Inc., Promaxo Inc.

How Is the Breast Biopsy Market Evolving?
Leading corporations in the breast biopsy market are concentrating on developing cutting-edge technologies like vacuum-assisted breast biopsy systems, aimed at enhancing patient care for individuals with benign breast lesions. A vacuum-assisted breast biopsy system, a piece of medical equipment, uses suction to extract multiple tissue samples from a potentially abnormal area of the breast using a single needle insertion. In August 2022, Devicor Medical Products, Inc., a medical device company based in the US, introduced the Mammotome Revolve EX Dual Vacuum-Assisted Breast Biopsy System. This system comprises a dual vacuum method to amplify tissue collection, providing superior volume sampling and heightened precision. The system's ergonomic configuration incorporates a rotating probe for optimal maneuverability and a one-time insertion process, reducing patient discomfort. Aside from that, it allows real-time imaging integration for accurate targeting and streamlined biopsy procedures.

What Are the Different Segmentations in the Breast Biopsy Market?
The breast biopsymarket covered in this report is segmented -

1) By Type: Biopsy Needles, Guidance Systems, Biopsy Tables, Localization Wires, Assay Kits, Liquid Biopsy Instruments, Other Types
2) By Image Guided Technology: Magnetic Resonance Imaging (MRI) Guided Breast Biopsy, Ultrasound Guided Breast Biopsy, Mammography Guided Stereotactic Biopsy, Computed Tomography (CT) Guided Biopsy, Other Image Guided Breast Biopsy
3) By Procedure: Needle Breast Biopsy, Open Surgical Breast Biopsy, Liquid Breast Biopsy
4) By Application: Hospitals, Clinics, Diagnostic Centers, Other Applications

Subsegments:
1) By Biopsy Needles: Core Biopsy Needles, Fine Needle Aspiration (FNA) Needles, Vacuum-Assisted Biopsy Needles, Automatic Biopsy Needles
2) By Guidance Systems: Ultrasound Guidance Systems, MRI Guidance Systems, Stereotactic Guidance Systems, Tomosynthesis Guidance Systems
3) By Biopsy Tables: Adjustable Biopsy Tables, Specialty Biopsy Tables, Imaging-Compatible Biopsy Tables
4) By Localization Wires: Hookwire Localization Devices, Radioguided Localization Wires, Magnetic Seed Localization Systems
5) By Assay Kits: Breast Cancer Assay Kits, Biomarker Detection Kits, Genetic Testing Kits for Breast Cancer
6) By Liquid Biopsy Instruments: Circulating Tumor Cell (CTC) Isolation Devices, Plasma DNA Isolation Kits, Liquid Biopsy Analysis Systems
7) By Other Types: Biopsy Adhesives, Specimen Collection and Transport Devices, Patient Management Systems

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/breast-biopsy-global-market-report

Which Region Is at the Forefront of the Breast Biopsy Market?
North America was the largest region in the breast biopsy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the breast biopsy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Is Covered In The Breast Biopsy Global Market Report?

- Market Size Analysis: Analyze the Breast Biopsy Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Breast Biopsy Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Breast Biopsy Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Breast Biopsy Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19348

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.